Inhibition of PADs by their inhibitor CI-amidine leads to the upregulation of OKL38 (oxidative stress-induced growth inhibitor 1), which promotes cell apoptosis and mitochondrial dysfunction in breast and osteosarcoma cells (Yao et al., 2008). The gene discussed is OSGIN1; the disease is osteosarcoma.